Literature DB >> 486218

Lymphocyte depletion by continuous flow cell centrifugation in rheumatoid arthritis: clinical effects.

J Karsh, D G Wright, J H Klippel, J L Decker, A B Deisseroth, M W Flye.   

Abstract

Four patients with active, severe rheumatoid arthritis were subjected to the removal of circulating lymphocytes (lymphapheresis) for a 6-week period by use of a continuous flow cell centrifuge. Repetitive venous access was gained through forearm arteriovenous fistulae. In all patients the Ritchie-Camp articular index declined rapidly in the first week and more slowly therafter for a total mean drop of 61% below the initial value. The index continued to decline after lymphapheresis but exacerbation of disease activity developed at an average of 19 weeks. No significant untoward effects of the procedure were observed; occasional transfusions were required to compensate for the small, unavoidable erythrocyte loss.

Entities:  

Mesh:

Year:  1979        PMID: 486218     DOI: 10.1002/art.1780221002

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  12 in total

Review 1.  Treatment of severe rheumatoid arthritis.

Authors:  V Wright
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-15

2.  Where now for therapeutic apheresis?

Authors:  T Hamblin
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-29

3.  Plasmapheresis in clinical medicine.

Authors:  C Linker
Journal:  West J Med       Date:  1983-01

4.  Removal of lymphocytes in rheumatoid arthritis.

Authors:  A M Denman
Journal:  Br Med J (Clin Res Ed)       Date:  1981-12-05

5.  Apheresis therapy: spin-drying the blood.

Authors:  T J Hamblin
Journal:  Br Med J (Clin Res Ed)       Date:  1982-10-23

6.  Activation pathways of synovial T lymphocytes. Expression and function of the UM4D4/CDw60 antigen.

Authors:  D A Fox; J A Millard; L Kan; W S Zeldes; W Davis; J Higgs; F Emmrich; R W Kinne
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

Review 7.  The optimum management of arthropathies.

Authors:  C S Wolfe; G R Hughes
Journal:  Drugs       Date:  1988-09       Impact factor: 9.546

8.  Lymphapheresis as compared with rest period in treatment of severe rheumatoid arthritis.

Authors:  A M Boerbooms; D J De Rooy; P J Geerdink; L B Van de Putte; F A Van den Ouweland
Journal:  Clin Rheumatol       Date:  1984-03       Impact factor: 2.980

9.  Exploring the feasibility of selective depletion of T lymphocyte subsets by whole blood immunoadsorption cytapheresis.

Authors:  M Belak; C R Valeri; D G Wright
Journal:  Clin Exp Immunol       Date:  2007-10-09       Impact factor: 4.330

10.  Modulation of monocyte activation in patients with rheumatoid arthritis by leukapheresis therapy.

Authors:  G Hahn; B Stuhlmüller; N Hain; J R Kalden; K Pfizenmaier; G R Burmester
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.